Supraphysiological levels of the osteoblast-enriched mineralisation regulator ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) is associated with type 2 diabetes mellitus. We determined the impact of osteoblast-specific Enpp1 ablation on skeletal structure and metabolic phenotype in mice. Female, but not male, 6-week old mice lacking osteoblast NPP1 expression (osteoblast- specific KO) exhibited increased femoral bone volume/total volume (17.50% vs 11.67%; p<0.01), and reduced trabecular spacing (0.187mm vs 0.157mm; P<0.01) compared with floxed (control) mice. Furthermore, an enhanced ability of isolated osteoblasts from the osteoblast-specific KO to calcify their matrix in vitro compared to fl/fl osteoblasts was observed (p<0.05).Male osteoblast-specific KO and fl/fl mice showed comparable glucose and insulin tolerance despite increased levels of insulin–sensitizing under-carboxylated osteocalcin (195% increase; p<0.05). However, following high-fat-diet challenge, osteoblast-specific KO mice showed impaired glucose and insulin tolerance compared with fl/fl mice. These data highlight a crucial local role for osteoblast NPP1 in skeletal development and a secondary metabolic impact that predominantly maintains insulin sensitivity.
|Journal||Journal of Cellular Physiology|
|Early online date||10 Dec 2020|
|Publication status||E-pub ahead of print - 10 Dec 2020|
- Bone-fat interactions
- Genetic animal models
- Matrix mineralization
- Non collagenous proteinss